Free Trial

Dr. Reddy's Laboratories (RDY) Short Interest Ratio & Short Volume

$69.53
-0.08 (-0.11%)
(As of 05/24/2024 ET)

Dr. Reddy's Laboratories Short Interest Data

Current Short Interest
867,900 shares
Previous Short Interest
751,000 shares
Change Vs. Previous Month
+15.57%
Dollar Volume Sold Short
$63.76 million
Short Interest Ratio
4.6 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
166,880,000 shares
Percentage of Shares Shorted
0.52%
Today's Trading Volume
257,351 shares
Average Trading Volume
265,657 shares
Today's Volume Vs. Average
97%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Dr. Reddy's Laboratories ?

Sign up to receive the latest short interest report for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RDY Short Interest Over Time

RDY Days to Cover Over Time

RDY Percentage of Float Shorted Over Time

Dr. Reddy's Laboratories Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2024867,900 shares $63.76 million +15.6%N/A4.6 $73.47
4/15/2024751,000 shares $53.45 million +20.0%N/A3.9 $71.17
3/31/2024625,800 shares $45.90 million -11.8%N/A3.2 $73.35
3/15/2024709,300 shares $53.36 million +9.4%N/A3.5 $75.23
2/29/2024648,100 shares $49.79 million -6.6%N/A2.8 $76.83
2/15/2024693,500 shares $52.03 million -9.7%N/A2.9 $75.02
1/31/2024768,000 shares $55.35 million +4.3%N/A3.2 $72.08
1/15/2024736,100 shares $51.07 million -13.4%N/A2.9 $69.38
12/31/2023849,500 shares $59.11 million -22.8%N/A3.3 $69.58
12/15/20231,100,000 shares $73.29 million -5.2%N/A4.1 $66.63
11/30/20231,160,000 shares $81.08 million +9.4%N/A4.4 $69.90
11/15/20231,060,000 shares $69.64 million -16.5%N/A4.3 $65.70
10/31/20231,270,000 shares $82.72 million +4.1%N/A4.3 $65.13
10/15/20231,220,000 shares $81.04 million +10.9%N/A4.1 $66.43
9/30/20231,100,000 shares $73.56 million -36.8%N/A3.8 $66.87
9/15/20231,740,000 shares $121.54 million +8.1%N/A6.3 $69.85
8/31/20231,610,000 shares $109.44 million -6.9%N/A6 $67.98
8/15/20231,730,000 shares $122.95 million +32.1%1.0%6.6 $71.07
7/31/20231,310,000 shares $89.97 million -4.4%0.8%5.4 $68.68
7/15/20231,370,000 shares $84.80 million -23.5%0.8%5.9 $61.90
6/30/20231,790,000 shares $112.99 million -4.3%N/A7.5 $63.13
6/15/20231,870,000 shares $111.07 million -1.1%N/A7.6 $59.40
5/31/20231,890,000 shares $104.31 million +3.3%N/A7.6 $55.19
5/15/20231,830,000 shares $101.20 million -3.7%N/A7.6 $55.30
4/30/20231,900,000 shares $114.87 million +7.3%N/A9 $60.46
4/15/20231,770,000 shares $106.36 million No ChangeN/A8.8 $60.09
3/31/20231,770,000 shares $100.77 million +29.2%N/A9.1 $56.93
3/15/20231,370,000 shares $73.13 million +1.5%N/A7.5 $53.38
2/28/20231,350,000 shares $70.54 million +6.3%N/A7.9 $52.25
2/15/20231,270,000 shares $70.09 million +7.6%N/A6.9 $55.19
1/31/20231,180,000 shares $63.48 million -12.6%N/A5.9 $53.80
1/15/20231,350,000 shares $72.36 million +16.4%N/A6.3 $53.60
12/30/20221,160,000 shares $60.03 million No ChangeN/A5.5 $51.75
12/15/20221,160,000 shares $62.08 million -8.7%N/A5.3 $53.52
11/30/20221,270,000 shares $71.51 million -2.3%N/A5.3 $56.31
11/15/20221,300,000 shares $71.54 million -19.8%N/A5.6 $55.03
10/31/20221,620,000 shares $87.98 million +3.9%N/A6.9 $54.31
10/15/20221,560,000 shares $80.71 million -12.9%N/A7.3 $51.74
9/30/20221,790,000 shares $93.69 million +5.9%N/A8 $52.34
9/15/20221,690,000 shares $87.39 million +13.4%N/A8 $51.71
Urgent Nvidia Warning (Ad)

Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.

Click here to access…
8/31/20221,490,000 shares $77.91 million +27.4%N/A7.2 $52.29
8/15/20221,170,000 shares $62.74 million +7.3%N/A5.7 $53.62
7/31/20221,090,000 shares $56.14 million -16.2%N/A5.5 $51.50
7/15/20221,300,000 shares $74.33 million No ChangeN/A6.6 $57.18
6/30/20221,300,000 shares $72.01 million -26.6%N/A6.8 $55.39
6/15/20221,770,000 shares $99.35 million -13.2%N/A8.4 $56.13
5/31/20222,040,000 shares $112.91 million +9.7%N/A10 $55.35
5/15/20221,860,000 shares $94.60 million +35.8%N/A8.6 $50.86
4/30/20221,370,000 shares $73.54 million +8.7%N/A6.5 $53.68
4/15/20221,260,000 shares $70.57 million +26.8%N/A6.1 $56.01
3/31/2022994,100 shares $55.40 million +1.4%N/A5 $55.73
3/15/2022980,600 shares $50.49 million +5.4%N/A6.1 $51.49
2/28/2022930,000 shares $49.68 million +2.6%N/A6 $53.42
2/15/2022906,500 shares $51.24 million +46.0%N/A6.6 $56.52
1/31/2022621,000 shares $35.71 million -13.4%N/A5.2 $57.50
1/15/2022717,300 shares $44.93 million +3.2%N/A6 $62.64
12/31/2021694,800 shares $45.45 million -2.7%N/A5.6 $65.41
12/15/2021713,700 shares $43.15 million -43.8%N/A5.1 $60.46
11/30/20211,270,000 shares $79.30 million -3.1%N/A9.7 $62.44
11/15/20211,310,000 shares $85.65 million +5.7%N/A10.4 $65.38
10/29/20211,240,000 shares $76.19 million -3.1%N/A9.9 $61.44
10/15/20211,280,000 shares $84.49 million +31.2%N/A9.9 $66.01
9/30/2021975,400 shares $63.54 million -13.7%N/A8 $65.14
9/15/20211,130,000 shares $76.13 million -1.7%N/A10 $67.37
8/31/20211,150,000 shares $73.84 million -1.7%N/A10 $64.21
8/13/20211,170,000 shares $73.37 million +17.6%0.7%10.6 $62.71
7/30/2021995,200 shares $62.25 million +3.4%0.6%8.5 $62.55
7/15/2021962,700 shares $69.83 million -22.4%0.6%8.4 $72.54
6/30/20211,240,000 shares $91.15 million +4.2%0.8%10 $73.51
6/15/20211,190,000 shares $87.71 million -10.5%0.7%8.5 $73.71
5/28/20211,330,000 shares $94.92 million +6.4%0.8%9 $71.37
5/14/20211,250,000 shares $90.68 million -3.9%N/A7 $72.54
4/30/20211,300,000 shares $89.65 million +26.2%N/A7 $68.96
4/15/20211,030,000 shares $64.97 million -6.4%N/A4.7 $63.08
3/31/20211,100,000 shares $67.23 million -17.3%N/A5.1 $61.12
3/15/20211,330,000 shares $81.04 million +3.9%N/A6.6 $60.93
2/26/20211,280,000 shares $77.58 million +10.3%N/A6.6 $60.61
2/12/20211,160,000 shares $76.77 million +6.4%N/A6.4 $66.18
1/29/20211,090,000 shares $72.01 million -1.8%N/A6.2 $66.06
1/15/20211,110,000 shares $79.93 million +31.3%N/A7 $72.01
12/31/2020845,300 shares $59.80 million +8.0%N/A5.3 $70.74
12/15/2020782,900 shares $53.25 million -3.9%N/A4.4 $68.02
11/30/2020814,800 shares $53.26 million +2.3%N/A4.3 $65.37
11/15/2020796,300 shares $51.24 million -10.4%N/A4.2 $64.35
10/30/2020888,300 shares $58.83 million -0.5%N/A5 $66.23
10/15/2020892,400 shares $62.30 million -15.8%N/A5.2 $69.81
9/30/20201,060,000 shares $73.73 million -26.9%N/A6.1 $69.56
9/15/20201,450,000 shares $87.71 million -2.0%N/A9.1 $60.49
8/31/20201,480,000 shares $86.09 million -2.6%N/A9 $58.17
8/14/20201,520,000 shares $92.40 million -2.6%N/A8.7 $60.79
Urgent Nvidia Warning (Ad)

Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.

Click here to access…
7/31/20201,560,000 shares $94.85 million +4.7%N/A8 $60.80
7/15/20201,490,000 shares $78.98 million No ChangeN/A7.4 $53.01
6/30/20201,490,000 shares $79.01 million +3.5%N/A6.6 $53.03
6/15/20201,440,000 shares $75.46 million -5.3%N/A6 $52.40
5/29/20201,520,000 shares $81.23 million No ChangeN/A6.3 $53.44
5/15/20201,520,000 shares $75.48 million +20.6%N/A6.5 $49.66
4/30/20201,260,000 shares $64.80 million -6.0%N/A5.6 $51.43
4/15/20201,340,000 shares $66.12 million +3.1%N/A5.6 $49.34
3/31/20201,300,000 shares $67.37 million +13.1%N/A5.7 $51.82
3/13/20201,149,000 shares $53.85 million -0.1%0.9%6.3 $46.87
2/28/20201,150,000 shares $42.18 million -0.9%0.7%6.3 $36.68
2/14/20201,160,000 shares $47.75 million -8.7%0.7%6.2 $41.16
1/31/20201,270,000 shares $54.71 million +0.8%0.8%7 $43.08
1/15/20201,260,000 shares $56.11 million -2.3%0.8%7 $44.53
12/31/20191,290,000 shares $54.18 million -6.5%0.8%8 $42.00

RDY Short Interest - Frequently Asked Questions

What is Dr. Reddy's Laboratories' current short interest?

Short interest is the volume of Dr. Reddy's Laboratories shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 867,900 shares of RDY short. Learn More on Dr. Reddy's Laboratories' current short interest.

What is a good short interest ratio for Dr. Reddy's Laboratories?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RDY shares currently have a short interest ratio of 5.0. Learn More on Dr. Reddy's Laboratories's short interest ratio.

Which institutional investors are shorting Dr. Reddy's Laboratories?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Dr. Reddy's Laboratories: Walleye Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Dr. Reddy's Laboratories' short interest increasing or decreasing?

Dr. Reddy's Laboratories saw a increase in short interest in April. As of April 30th, there was short interest totaling 867,900 shares, an increase of 15.6% from the previous total of 751,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Dr. Reddy's Laboratories' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Dr. Reddy's Laboratories: Sarepta Therapeutics, Inc. (6.02%), United Therapeutics Co. (9.42%), Catalent, Inc. (3.67%), Viatris Inc. (3.84%), Elanco Animal Health Incorporated (2.73%), BioMarin Pharmaceutical Inc. (2.06%), Legend Biotech Co. (7.29%), Cerevel Therapeutics Holdings, Inc. (7.57%), Ascendis Pharma A/S (6.36%), Viking Therapeutics, Inc. (10.98%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Dr. Reddy's Laboratories stock?

Short selling RDY is an investing strategy that aims to generate trading profit from Dr. Reddy's Laboratories as its price is falling. RDY shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Dr. Reddy's Laboratories?

A short squeeze for Dr. Reddy's Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RDY, which in turn drives the price of the stock up even further.

How often is Dr. Reddy's Laboratories' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RDY, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NYSE:RDY) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners